GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (FRA:BTL) » Definitions » Earnings per Share (Diluted)

Baxter International (FRA:BTL) Earnings per Share (Diluted)

: €4.89 (TTM As of Dec. 2023)
View and export this data going back to . Start your Free Trial

Baxter International's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was €0.44. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €4.89.

Baxter International's EPS (Basic) for the three months ended in Dec. 2023 was €0.44. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €4.90.

Baxter International's EPS without NRI for the three months ended in Dec. 2023 was €0.81. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €0.67.

During the past 13 years, Baxter International's highest 3-Year average EPS without NRI Growth Rate was 277.20% per year. The lowest was -49.10% per year. And the median was 8.40% per year.


Baxter International Earnings per Share (Diluted) Historical Data

The historical data trend for Baxter International's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.74 1.75 2.24 -4.56 4.81

Baxter International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings per Share (Diluted) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.08 -0.26 4.62 0.44

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Baxter International's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baxter International PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's PE Ratio distribution charts can be found below:

* The bar in red indicates where Baxter International's PE Ratio falls into.



Baxter International Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Baxter International's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(2435.552-0)/506.000
=4.81

Baxter International's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(224.665-0)/506.000
=0.44

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Baxter International  (FRA:BTL) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Baxter International Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Baxter International's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Baxter International (FRA:BTL) Business Description

Traded in Other Exchanges
Address
One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.

Baxter International (FRA:BTL) Headlines

No Headlines